Clinical Trials Directory

Trials / Completed

CompletedNCT06709807

Clinical Study to Evaluate the Food Effect of CKD-378 in Healthy Volunteers

An Open-label, Randomized, Single-dose, 2-sequence, 2-period, Crossover Study to Evaluate the Food Effect on the Safety and the Pharmacokinetics of CKD-378 in Healthy Adult Volunteers

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
31 (actual)
Sponsor
Chong Kun Dang Pharmaceutical · Industry
Sex
All
Age
19 Years
Healthy volunteers
Accepted

Summary

This study is a randomized, open-label, single dose, crossover study to evaluate the food effect of CKD-378 in healthy volunteers

Detailed description

To 30 healthy subjects, following treatments are administered dosing in each period and wash-out period is 7 days. Pharmacokinetic blood samples are collected up to 48hrs. The pharmacokinetic characteristics and safety are assessed.

Conditions

Interventions

TypeNameDescription
DRUGCKD-378 25/1000mgQD, PO

Timeline

Start date
2024-11-08
Primary completion
2024-12-07
Completion
2024-12-19
First posted
2024-11-29
Last updated
2025-05-21

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT06709807. Inclusion in this directory is not an endorsement.